載入...
Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
Intravenous immunoglobulin (IVIG), a pooled normal IgG from several thousand healthy donors and one of the commonly used immunotherapeutic molecules for the management of autoimmune and inflammatory diseases, has been explored for the treatment of coronavirus disease‐19 (COVID‐19). Although placebo‐...
Na minha lista:
| 發表在: | Clin Transl Immunology |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565103/ https://ncbi.nlm.nih.gov/pubmed/33088506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1198 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|